Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

481 ARTÍCULOS , VIENDO DEL 301 AL 315

What plasma biomarkers tell us about hippocampal microstructural changes in Alzheimer's disease

Toniolo S.

Brain. 2022 Jun 30;145(6):1880-1882. doi: 10.1093/brain/awac190.

Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials

Ossenkoppele R, van der Kant R, Hansson O.

Lancet Neurol. 2022 Aug;21(8):726-734. doi: 10.1016/S1474-4422(22)00168-5. Epub 2022 May 25.

Quantifying cerebrospinal fluid dynamics: A review of human neuroimaging contributions to CSF physiology and neurodegenerative disease

Mehta NH, Suss RA, Dyke JP, Theise ND, Chiang GC, Strauss S, Saint-Louis L, Li Y, Pahlajani S, Babaria V, Glodzik L, Carare RO, de Leon MJ.

Neurobiol Dis. 2022 Aug;170:105776. doi: 10.1016/j.nbd.2022.105776. Epub 2022 May 25.

[Prognostic and diagnostic value of cerebrospinal fluid analysis in neurodegenerative dementia diseases]

Haußmann R, Homeyer P, Brandt MD, Donix M.

Nervenarzt. 2022 Dec;93(12):1236-1242. doi: 10.1007/s00115-022-01339-6. Epub 2022 Jun 7.

Alzheimer Disease

McDade EM.

Continuum (Minneap Minn). 2022 Jun 1;28(3):648-675. doi: 10.1212/CON.0000000000001131.

Atypical Alzheimer Disease Variants

Polsinelli AJ, Apostolova LG.

Continuum (Minneap Minn). 2022 Jun 1;28(3):676-701. doi: 10.1212/CON.0000000000001082.

Fluid Biomarkers in Dementia Diagnosis

Schindler SE.

Continuum (Minneap Minn). 2022 Jun 1;28(3):822-833. doi: 10.1212/CON.0000000000001083.

Neuroimaging Modalities in Alzheimer's Disease: Diagnosis and Clinical Features

Kim J, Jeong M, Stiles WR, Choi HS.

Int J Mol Sci. 2022 May 28;23(11):6079. doi: 10.3390/ijms23116079.

Biomarkers for Alzheimer's disease: Earlier, easier, and fairer

eBioMedicine.

EBioMedicine. 2022 Jun;80:104114. doi: 10.1016/j.ebiom.2022.104114.

Primary progressive aphasia: ReADing the clinical GRANularity

Chokesuwattanaskul A, Marshall CR, van Harskamp N, Houlden H, Rohrer JD, Hardy CJ, Warren JD.

Pract Neurol. 2022 Dec;22(6):509-514. doi: 10.1136/practneurol-2022-003460. Epub 2022 Jun 16.

Attention-guided neural network for early dementia detection using MRS data

Kherchouche A, Ben-Ahmed O, Guillevin C, Tremblais B, Julian A, Fernandez-Maloigne C, Guillevin R.

Comput Med Imaging Graph. 2022 Jul;99:102074. doi: 10.1016/j.compmedimag.2022.102074. Epub 2022 May 27.

Predictive Accuracy of Digital Biomarker Technologies for Detection of Mild Cognitive Impairment and Pre-Frailty Amongst Older Adults: A Systematic Review and Meta-Analysis

Teh SK, Rawtaer I, Tan HP.

IEEE J Biomed Health Inform. 2022 Aug;26(8):3638-3648. doi: 10.1109/JBHI.2022.3185798. Epub 2022 Aug 11.

Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer's Disease

Bousiges O, Blanc F.

Int J Mol Sci. 2022 Jun 7;23(12):6371. doi: 10.3390/ijms23126371.

MicroRNA-29c-3p in dual-labeled exosome is a potential diagnostic marker of subjective cognitive decline

Li Y, Xia M, Meng S, Wu D, Ling S, Chen X, Liu C.

Neurobiol Dis. 2022 Sep;171:105800. doi: 10.1016/j.nbd.2022.105800. Epub 2022 Jun 22.

Association between obstructive sleep apnea and Alzheimer's disease-related blood and cerebrospinal fluid biomarkers: A meta-analysis

Kang J, Tian Z, Wei J, Mu Z, Liang J, Li M.

J Clin Neurosci. 2022 Aug;102:87-94. doi: 10.1016/j.jocn.2022.06.004. Epub 2022 Jun 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias